$35M Teva QVAR Inhaler Settlement, Check If You Qualify and How to Get Paid July 31 is Deadline 

The Teva QVAR Antitrust Settlement is a $35,000,000 price-fixing class action where eligible consumers and health plan members who purchased QVAR or QVAR Redihaler inhalers can receive a payment by filing a claim before July 31, 2026. Plaintiffs accused Teva Pharmaceutical Industries of illegally blocking cheaper generic versions of QVAR from reaching the market, forcing people with asthma to pay inflated brand-name prices for years. The settlement received preliminary approval from U.S. District Judge Nathaniel M. Gorton in April 2026.

Teva QVAR Settlement — Quick Facts

Field	Detail
Settlement Amount	$35,000,000
Claim Deadline	July 31, 2026
Who Qualifies	Individuals and entities who purchased, paid for, or reimbursed QVAR or QVAR Redihaler from January 1, 2015 through July 31, 2025 in covered states
Payout Per Person	TBD — depends on number of valid claims filed and total QVAR purchases documented
Proof Required	Yes — total out-of-pocket amount paid for QVAR products
Settlement Status	Preliminarily Approved — pending final court approval
Administrator	A.B. Data, Ltd.
Official Website	QVARantitrustsettlement.com
Last Updated	May 5, 2026

Current Status of the Teva QVAR Case

• Judge Gorton granted preliminary approval on April 2, 2026. The settlement is not yet final.
• The Final Approval (Fairness) Hearing is scheduled for August 5, 2026 in Boston, Massachusetts.
• Payments will not go out until after final approval and all claims are processed — this typically takes several months after the hearing.

What Is the Teva QVAR Lawsuit About? Iron Workers District Council of New England Health and Welfare Fund et al. v. Teva, No. 1:23-cv-11131

The lawsuit, filed in 2023 in the U.S. District Court for the District of Massachusetts, accuses Teva of violating federal and state antitrust and consumer protection laws by rigging the market to block generic QVAR inhalers.

Plaintiffs accused Teva of improperly listing patents in the FDA’s Orange Book and engaging in “sham” litigation to shield QVAR from generic competition. When a brand-name drug company lists patents in the Orange Book, it can trigger an automatic 30-month delay on any generic version — even if those patents don’t legally qualify to be listed there.

Plaintiffs also alleged Teva paid Amneal Pharmaceuticals to delay releasing a generic version of the product — a practice commonly called a “pay-for-delay” deal. On top of that, the lawsuit alleges Teva discontinued certain versions of QVAR and switched to new versions specifically to obtain new patent protection — what antitrust lawyers call a “product hop.” The result, according to plaintiffs, is that people with asthma paid inflated prices for QVAR for nearly a decade when cheaper generics should have been available. If you want to understand how these kinds of tactics affect consumers broadly, our guide to consumer class action lawsuits breaks down the full picture.

Teva denied all wrongdoing. No court determined that Teva violated the law — the settlement is a negotiated resolution to avoid a trial.

Who Qualifies for the Teva QVAR Antitrust Settlement?

If you’re wondering whether you’re eligible for this class action settlement payout, here’s how to check. You may qualify if you meet all of the following:

• You may qualify if you purchased QVAR or QVAR Redihaler inhalers for personal or family use (not for resale) between January 1, 2015 and July 31, 2025
• You may qualify if your purchase was made in one of these covered states or territories: Alaska, Arkansas, Arizona, California, Connecticut, Delaware, D.C., Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Maine, Massachusetts, Maryland, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, West Virginia, Wisconsin, or Wyoming
• You may qualify if you are a health plan, union fund, insurance company, or other third-party payor that reimbursed QVAR purchases during the class period in covered states

Related article: $800k BMW Shark Fin Antenna Settlement, Do You Qualify for Repair Reimbursement? Deadline is August 27

You do NOT qualify if:

• You are a government entity (federal or state)
• You are a Teva subsidiary or affiliate
• You purchased QVAR for resale rather than personal or member use
• Your purchases happened entirely outside the listed states

If you’re unsure, call the settlement administrator at 1-866-588-8524 or visit QVARantitrustsettlement.com. Similar pharmaceutical pricing cases.

How Much Can You Get from the Teva QVAR Settlement?

The exact legal settlement payout per person is not yet confirmed. Here’s how the money will be split:

The Net Settlement Fund (after attorneys’ fees, costs, and service awards) will be divided into two funds: the Consumer Fund at 20.7% and the Third-Party Payor Fund at 79.3%. Each eligible claimant’s payment will be calculated proportionally (pro rata) based on how much QVAR they purchased relative to all valid claims submitted.

In plain terms: the more QVAR you purchased, and the fewer people who file claims, the larger your individual payment. Because this is a pro-rata settlement, Teva is not writing a fixed check per person — your share grows or shrinks based on how many people participate.

Up to 33% of the $35,000,000 fund may go to attorneys’ fees, plus up to $890,000 in litigation costs and $25,000 service awards to each of the four class representatives. That leaves an estimated net fund of roughly $22,000,000 split across all valid claimants. Filing is free — no consumer rights lawyer or paid representative is needed to submit a claim.

How to File Your Teva QVAR Settlement Claim

Here is exactly how to file a legal claim for this settlement — it takes about 10 minutes:

Step 1 — Go to QVARantitrustsettlement.com and locate the Claim Form section.

Step 2 — Select the correct form: Consumer Claim Form (for individuals) or Third-Party Payor Claim Form (for health plans and insurance entities).

Step 3 — Enter your personal details including name, address, and contact information.

Step 4 — Provide your total out-of-pocket amount paid for QVAR or QVAR Redihaler during the class period. Have your pharmacy receipts, insurance statements, or prescription records ready if available.

Step 5 — Submit online at the settlement website or mail your completed form to: QVAR Antitrust Settlement, c/o A.B. Data, Ltd., P.O. Box 173034, Milwaukee, WI 53217.

Step 6 — Save your confirmation number or keep a copy of your mailed form.

Estimated time to complete: 10 minutes.

Key Deadlines in the Teva QVAR Settlement

Milestone	Date
Preliminary Court Approval	April 2, 2026
Claims Period Opens	April 2026
Claim Filing Deadline	July 31, 2026
Opt-Out Deadline	June 15, 2026
Objection Deadline	June 15, 2026
Final Approval Hearing	August 5, 2026
Expected Payment Date	TBD — several months after final approval

Frequently Asked Questions

Is there a class action lawsuit against Teva for QVAR inhalers?

 Yes. Iron Workers District Council of New England Health and Welfare Fund et al. v. Teva, No. 1:23-cv-11131, was filed in the U.S. District Court for the District of Massachusetts in 2023. The $35,000,000 settlement received preliminary approval in April 2026.

Do I qualify for the Teva QVAR settlement? 

You likely qualify if you purchased or paid for QVAR or QVAR Redihaler in one of 42 covered states between January 1, 2015 and July 31, 2025. Health plans and insurers that reimbursed QVAR costs may also file as third-party payors.

How do I file a Teva QVAR settlement claim?

 File online at QVARantitrustsettlement.com or mail your completed Consumer Claim Form to A.B. Data, Ltd., P.O. Box 173034, Milwaukee, WI 53217. Your claim must be submitted by July 31, 2026.

Do I need a lawyer to file a claim? 

No. Filing directly through the settlement website is free and straightforward. A class action lawsuit attorney is not required — class counsel from Berman Tabacco and Sperling Kenny Nachwalter already represent all class members at no direct cost to you.

Is this settlement legitimate?

 Yes. The settlement was filed in federal court in Massachusetts and received preliminary approval from U.S. District Judge Nathaniel M. Gorton on April 2, 2026. Administrator A.B. Data, Ltd. is a well-established claims administrator.

When will I receive my payment? 

No payments will go out until after the Final Approval Hearing on August 5, 2026, and after A.B. Data finishes processing all claims. Expect several months after final approval before checks are distributed.

What if I missed the claim deadline?

 The deadline is July 31, 2026. If you miss it, you will not receive a payment from this settlement and will remain bound by the settlement’s terms. There is no late filing option.

Will this settlement payment affect my taxes?

 Possibly. Payments that compensate for economic overcharges may be considered taxable income depending on your situation. This article is not tax advice — consult a tax professional about how a lawsuit settlement check could affect your tax return.

Sources & References

• Official Settlement Notice (May 1, 2026): QVARantitrustsettlement.com
• Reuters / PYMNTS: Teva Settles Claims Alleging It Blocked Cheaper QVAR Alternatives (October 2025): pymnts.com
• MLex: Teva Settlement Gets Preliminary Nod (April 2, 2026): mlex.com

Prepared by the AllAboutLawyer.com Editorial Team and reviewed for factual accuracy against the official court notice and settlement administrator website on May 5, 2026. Last Updated: May 5, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.